ExpertiseUpdated on 17 February 2026
CMC Leadership for Biologics: From Concept to Commercial Manufacturing
About
We offer hands-on CMC leadership to take biologic programs from concept through Phase I and into commercial manufacturing. The focus is practical execution: designing a manufacturable process early, building the right analytics and potency logic, and scaling with disciplined tech transfer and quality systems.
We can support partners with:
-
End-to-end CMC strategy and stage-appropriate execution plans
-
Process concept, development, scale-up, and manufacturability decisions
-
Analytical strategy, potency, and control strategy aligned with clinical and commercial needs
-
Tech transfer packages and oversight across internal teams and CDMOs
-
GMP readiness, comparability thinking, and risk management to avoid late surprises
If you need a CMC-led execution partner who turns science into a robust, scalable manufacturing path, I’d welcome a conversation.
Field
- Biotech, Pharma and Cosmetics
Organisation
Similar opportunities
Partnership
EU GMP Clinical Manufacturing Partner for Phase I Supply
Ramtin Rahbar
Co-founder and Chief Technical Officer at Ness Therapeutics
Toronto, Canada
Expertise
ATMP Process Development & Bioproduction Maturation
- Biotech, Pharma and Cosmetics
Angèle Boyard
Business developer bioproduction at EFS BFC
Besançon, France
Project cooperation
Portfolio Company Collaboration: ENABLE Biotech
- Early
- Planning
- Research
- Execution
- Technical
- EU projects
- Biotech, Pharma and Cosmetics
Renaud Jacquemart
CEO at Omnium Global
Burlington, Canada